Caplin Point Laboratories LimitedNSE: CAPLIPOINT

Press Release Jul 14 2021

Jul 14, 2021 at 5:30 PM UTC

Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated July 14, 2021, titled "CAPLIN STERILES GETS USFDA APPROVAL FOR SUMATRIPTAN INJECTION".

View Attachment